Ranbaxy Laboratories, Dr Reddy's, Nicholas Piramal and three other Indian drug...
The auto maker is on a rough road with demand for both CVs and cars sluggish. With...
The credit growth in the current financial year has slowed down to 22.6 per cent at...
Leading Indian pharmaceutical companies, which are largely focused on the global...
Pharma firms have slowed down on R&D activities in a bid to control costs.
The FIIs' stake in Reliance Industries has increased from 20.22 per cent at the end of...
Birla patriarch, B K Birla's decision to give Kesoram Industries to his grandson...
Acquisition will ensure iron reserves for Vedanta.
Foreign institutional investors have shown signs of reducing their exposure to the oil...
With 62 filings, domestic pharma companies have filed the maximum number of drug master...